Clinical Handbook of Psychotropic Drugs for Children & Adolescents

Clinical Handbook of Psychotropic Drugs for Children & Adolescents
 Spiral binding
Nicht lieferbar | Lieferzeit: Nicht lieferbar I

79,95 €* Spiral binding

Alle Preise inkl. MwSt. | Versandkostenfrei
Artikel-Nr:
9780889374560
Einband:
Spiral binding
Seiten:
362
Autor:
Dean Elbe
Gewicht:
1210 g
Format:
283x243x29 mm
Sprache:
Englisch
Beschreibung:

Fully updated and expanded, in full color with intuitive icons throughout, packed with its unique comparison charts, and with patient handouts as printable PDFs - the widely acclaimed reference to psychotropic medications in children and adolescents is now more "user-friendly" than ever!

This unique book fills the need for a comprehensive, yet compact and easy-to-use reference for all mental health professionals dealing with children and adolescents. Packed with the practical comparison charts for which it is renowned, other outstanding features of the Clinical Handbook of Psychotropic Drugs for Children and Adolescents are:

- Independent, unbiased
- Unique comparison charts (dosages, side effects, pharmacokinetics, interactions...) that allow you to see at a glance which medication is the most suitable for each patient
- Instantly recognizable icons and full color throughout
- Compiles the latest information from the published literature (scientific data, controlled clinical trials, case reports) and clinical experience in one easy-to-use reference
- Includes monograph statements on use in children and adolescents and approved indications, as well as available data concerning off-label indications, findings from open and double-blind studies concerning doses, adverse effects, and other considerations
- Succinct, bulleted information on all classes of medication: classification, available products (including US and Canadian trade names), on- and off-label indications (US FDA and Canada); pharmacology, dosing, pharmacokinetics; adverse effects, precautions, contraindications, toxicity; lab tests, precautions, nursing implications; drug interactions; patient and caregiver instructions. All you need to know for each class of drug!!
Table of Contents Psychiatric Disorders in Children and Adolescents Attention-Deficit/Hyperactivity Disorder (ADHD) Major Depressive Disorder (MDD) Disruptive Mood Dysregulation Disorder (DMDD) Bipolar Disorder (BD) Schizophrenia ANXIETY DISORDERS Separation Anxiety Disorder Generalized Anxiety Disorder (GAD) Social Anxiety Disorder Panic Disorder Specific Phobia Obsessive-Compulsive Disorder (OCD) TRAUMA- AND STRESSOR-RELATED DISORDERS Posttraumatic Stress Disorder (PTSD) TIC DISORDERS Tourette's Disorder Autism Spectrum Disorder (ASD) DISRUPTIVE, IMPULSE-CONTROL, AND CONDUCT DISORDERS Conduct Disorder (CD) Oppositional Defiant Disorder (ODD) Drugs for ADHD Psychostimulants Atomoxetine Comparison of Drugs for ADHD α2 Agonists Augmentation Strategies in ADHD Antidepressants Selective Serotonin Reuptake Inhibitors (SSRI) Norepinephrine Dopamine Reuptake Inhibitor (NDRI) Serotonin Norepinephrine Reuptake Inhibitor (SNRI) Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) Serotonin-1A Agonist/Serotonin Reuptake Inhibitor Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) Nonselective Cyclic Antidepressants Monoamine Oxidase Inhibitors Reversible Inhibitor of MAO-A (RIMA) Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) Effects of Antidepressants on Neurotransmitters/Receptors Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses Antidepressant Doses and Pharmacokinetics Switching Antidepressants Antidepressant Augmentation Strategies Electroconvulsive Therapy (ECT) Antipsychotics "Second-Generation" Antipsychotics/SGAs "Third-Generation" Antipsychotic/TGA "First-Generation" Antipsychotics/FGAs Effects of Antipsychotics on Neurotransmitters/Receptors Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptors Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses Antipsychotic Doses and Pharmacokinetics (Oral and Short- Acting Injections) Comparison of Long-Acting IM Antipsychotics Switching Antipsychotics Antipsychotic Augmentation Strategies Antipsychotic-Induced Extrapyramidal Side Effects (EPSE) and Their Management Extrapyramidal Side Effects of Antipsychotics Treatment Options for Extrapyramidal Side Effects Effects on Extrapyramidal Symptoms Comparison of Agents for Treating Acute Extrapyramidal Side Effects Doses and Pharmacokinetics of Agents for Treating Acute Extrapyramidal Side Effects Anxiolytic (Antianxiety) Agents Benzodiazepines Comparison of the Benzodiazepines Buspirone Hypnotics/Sedatives Comparison of Hypnotics/Sedatives Mood Stabilizers Lithium Anticonvulsants Comparison of Anticonvulsants Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic Doses Drugs/Substances of Abuse Alcohol Stimulants Hallucinogens Opioids Inhalants/Aerosols Sodium Oxybate (Gamma-Hydroxybutyrate - GHB) Flunitrazepam (Rohypnol) Nicotine/Tobacco Treatment of Substance Use Disorders Disulfiram Acamprosate Naltrexone Methadone Buprenorphine Pharmacotherapy for Nicotine/Tobacco Use Dependence Unapproved Treatments of Psychiatric Disorders Adrenergic Agents Cholinergic Agents Dopaminergic Agents GABA Agents/Anticonvulsants Miscellaneous NMDA Agents Natural Health Products Glossary Drug Use in Pregnancy and Effects on Breast Milk Patient and Caregiver Information Sheets Index of Drugs

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.